Journal issues > Issue 3, March 2021 > P17 Efficacy of palliative metronomic chemotherapy: A retrospective analysis of the 15 years experience at CHU UCL Namur site Godinne

P17 Efficacy of palliative metronomic chemotherapy: A retrospective analysis of the 15 years experience at CHU UCL Namur site Godinne

By: Catherine Percy , Géraldine Rosier , Claire Barani , Fanny Collette , Laurence Faugeras , Lionel D'Hondt

Background: Metronomic chemotherapy consists of low-dose oral chemotherapy given continuously. The antitumor activity is supposed to be due to antiangiogenic and immunomodulation effects. This retrospective analysis was done to evaluate the benefit-risk balance of this treatment in palliative setting for unselected metastatic cancer patients.

To read the full artice you have the following options:

* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)

Purchase this article for €3.03

** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)

Top